Skip to main content

Peer Review reports

From: Real-world study of bevacizumab treatment in patients with ovarian cancer: a Chinese single-institution study of 155 patients

Original Submission
5 Aug 2022 Submitted Original manuscript
3 Sep 2022 Author responded Author comments - Nan Zhang
Resubmission - Version 2
3 Sep 2022 Submitted Manuscript version 2
29 Jan 2023 Reviewed Reviewer Report
17 Feb 2023 Reviewed Reviewer Report
28 Feb 2023 Author responded Author comments - Nan Zhang
Resubmission - Version 3
28 Feb 2023 Submitted Manuscript version 3
11 Mar 2023 Reviewed Reviewer Report
27 Mar 2023 Author responded Author comments - Nan Zhang
Resubmission - Version 4
27 Mar 2023 Submitted Manuscript version 4
Publishing
3 Apr 2023 Editorially accepted
13 Apr 2023 Article published 10.1186/s12905-023-02329-9

You can find further information about peer review here.

Back to article page